About 3 weeks ago I posted this, basically about PSMA uptake (DCFPyL scan) in a small area of liver without a CT correlate:
healthunlocked.com/advanced...
A followup MRI showed no hepatic metastasis. However, my oncologist and her radiologist are assuming that, regardless, there is moderate to high probability that this is liver PCa metastasis....even though (1) this would be an uncommon finding for someone with my history (locoregional lymph mets in pelvic area only for about 7 years now), (2) they characterize the appearance as a bit “weird” and “very tiny” (although no size has been determined), and (3) there is no correlation in either CT or MRI. The SUV uptake in that liver spot is 16, while the uptake in other spots range from 7-34.
MO admits this may instead be some kind of “metabolic response” that is not cancer, and as such should remain the same size when I scan again after 6 months of lupron/abiraterone. I would also speculate that it might just disappear entirely (see below for my reasoning), while PCa lesions will simply get smaller.
One thing I didn’t mention is that I’ve been taking about 800mg of EGCG since April 2020 (and the stopped altogether just before the PyL scan). From my own research, I have found it’s feasible that EGCG can induce hepatotoxicity, and other non-malignant conditions can in fact cause PSMA uptake; liver enzymes are often elevated from the EGCG, although for me this has not the case.
Can hepatotoxicity occur without elevated liver enzymes, and if so can this cause PSMA uptake?
Regardless, is my speculation reasonable, that the EGCG could have caused some metabolic response resulting in false positive PSMA uptake? If so, do you have a sense of the probability?
Is it reasonable to think that, unless this is permanent liver damage/other condition, that this “metabolic response” would disappear within 6 months (now that I’ve stopped the EGCG)?
Finally is it reasonable to assume that if the spot has either remained the same size, or has disappeared completely, after 6 months lupron/abi, that we can rule out prostate metastasis?
I also welcome your own speculations and insights, and any suggestions for what questions to ask my MO. Thanks very much in advance for anyone’s thoughts.